Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALS Untangled does not endorse insulin treatment for ALS

Original source

InsulinALSUntangled · 7 December 2023 (opens in a new tab)

ALS Untangled says insulin is an area for future research but is not supported as an ALS treatment at present. It reports no clinical evidence that insulin slows, stops or reverses ALS progression in people with ALS (PALS).

Why this matters

People with ALS should not view insulin as an established treatment based on current evidence. Insulin administration can carry significant and potentially lethal risks, according to the review.

Limitations and context

This conclusion comes from an independent expert review, not a new clinical trial. The review says further research may be warranted, but it does not provide evidence that insulin benefits people with ALS.

Summarised by Compass 9 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?